Gilead's Liver-Drug Setback Jeopardizes $35 Billion Dream

·

·

Gilead's Liver-Drug Setback Jeopardizes $35 Billion Dream

A trial failure adds to doubts about the drugmaker's focus on NASH treatments as a golden goose. By. Max Nisen. February 12, 2019, 6:21 AM PST
See Original Article

Beer giant Molson Coors slides after missing on sales and saying it made accounting errors

The company said it would restate its financial statements for fiscal 2016 and 2017 after its audit committee identified some accounting errors.
See Original Article

Controllers feel pressure to cook the books

The survey, by FloQast, a provider of close management software for corporate accounting departments, found that 64 percent of controllers feel
See Original Article

Apple and Google Caught Hosting Saudi Govt App That Tracks Women

A few days ago, The Insider published an article regarding the existence of Absher: an app that tracks movements of women. The report also included the story of a teen that successfully evaded Saudi Arabia.
See Original Article

National Society of Accountants announces 2019 scholarships

The National Society of Accountants Scholarship Foundation has announced that it is accepting applications for its 2019-2020 academic scholarships.
See Original Article



Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.